Upregulation of PPARα induces the transcription of BNIP3, thereby maintaining mitochondrial homeostasis, reducing kidney injury and delaying the transition from AKI to CKD in IRI and cisplatin-induced AKI models (Yao et al., 2022). This evidence concerns the gene BNIP3 and chronic kidney disease.